Reports regarding lncRNA MIR200CHG has been contradictory considering its role in regulating EMT in other cancer types but in case of Microsatellite stable/epithelial-mesenchymal transition subtype of gastric cancer it has been established with solid evidence that MIR200CHG is a master regulator of EMT and promoter hypermethylation-mediated MIR200CHG silencing is attributed to poor prognosis in gastric cancer patients (Zhu et al., 2023). The gene discussed is MIR200CHG; the disease is gastric cancer.